Content Provider
Sponsored by
Mjff2 logo
Handout Materials
Presentation Slides
Additional Materials
Webinar Technical FAQs
Free cpe webinars
Estate Planning Tips and Current Updates


Cost Free
Presentation Length 1.0 hour

Recorded DateMay 9, 2022
CPE:Not available
(archived webinars do not offer CPE credits)
Subject AreaTaxes
Course LevelBasic
Course Description

This program will explain the practical implications of recent estate planning developments that affect CPAs as well as practical planning tips to use with clients now. Recent developments will address: the Smaldino case and its implications to step transactions and proper tax compliance to coordinate with the estate plan; a recent GRAT CCA that affects all valuations and perhaps defined value mechanisms; and lessons from the Levine case on how to do estate planning right (even if you never see a split-dollar arrangement).

Learning Objectives:

  • Recall practical estate planning tips on trust income taxation

  • Define asset protections

  • Identify basic documents you and your clients need

  • Recognize creative uses of revocable trusts that CPAs should know

Not logged

Martin Shenkman

Shenkman Law
Dual Practitioner, Financial Planner
(201) 845-8400


Martin M. Shenkman, CPA, MBA, PFS, AEP (distinguished), JD, is an attorney in private practice in Fort Lee, New Jersey, and New York City, New York, with Shenkman Law. His practice focuses on estate and tax planning as well as planning for closely-held businesses and estate administration. Throughout his career, Mr. Shenkman received awards and acknowledgments from the New Jersey Bar Association, Worth Magazine, CPA Magazine, the American Cancer Society, and the AICPA. Mr. Shenkman holds a Bachelor of Science from the Wharton School at the University of Pennsylvania, an MBA from the University of Michigan, a law degree from Fordham University School of Law. He is admitted to the bar in New York, New Jersey, and Washington D.C.

About Our Sponsor

Mjff2 logo
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.